» Articles » PMID: 39916963

Colorimetric Aptasensor Coupled with a Deep-learning-powered Smartphone App for Programmed Death Ligand-1 Expressing Extracellular Vesicles

Overview
Journal Front Immunol
Date 2025 Feb 7
PMID 39916963
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer is a devastating public health threat and a leading cause of cancer-related deaths. Therefore, it is imperative to develop sophisticated techniques for the non-invasive detection of lung cancer. Extracellular vesicles expressing programmed death ligand-1 (PD-L1) markers (PD-L1@EVs) in the blood are reported to be indicative of lung cancer and response to immunotherapy. Our approach is the development of a colorimetric aptasensor by combining the rapid capturing efficiency of (FeO)-SiO-TiO for EV isolation with PD-L1 aptamer-triggered enzyme-linked hybridization chain reaction (HCR) for signal amplification. The numerous HRPs catalyze their substrate dopamine (colorless) into polydopamine (blackish brown). Change in chromaticity directly correlates with the concentration of PD-L1@EVs in the sample. The colorimetric aptasensor was able to detect PD-L1@EVs at concentrations as low as 3.6×10 EVs/mL with a wide linear range from 10 to 10 EVs/mL with high specificity and successfully detected lung cancer patients' serum from healthy volunteers' serum. To transform the qualitative colorimetric approach into a quantitative operation, we developed an intelligent convolutional neural network (CNN)-powered quantitative analyzer for chromaticity in the form of a smartphone app named ExoP, thereby achieving the intelligent analysis of chromaticity with minimal user intervention or additional hardware attachments for the sensitive and specific quantification of PD-L1@EVs. This combined approach offers a simple, sensitive, and specific tool for lung cancer detection using PD-L1@EVs. The addition of a CNN-powered smartphone app further eliminates the need for specialized equipment, making the colorimetric aptasensor more accessible for low-resource settings.

References
1.
Kang W, Liu L, Yu P, Zhang T, Lei C, Nie Z . A switchable Cas12a enabling CRISPR-based direct histone deacetylase activity detection. Biosens Bioelectron. 2022; 213:114468. DOI: 10.1016/j.bios.2022.114468. View

2.
Boriachek K, Masud M, Palma C, Phan H, Yamauchi Y, Hossain M . Avoiding Pre-Isolation Step in Exosome Analysis: Direct Isolation and Sensitive Detection of Exosomes Using Gold-Loaded Nanoporous Ferric Oxide Nanozymes. Anal Chem. 2019; 91(6):3827-3834. DOI: 10.1021/acs.analchem.8b03619. View

3.
Niu M, Liu Y, Yi M, Jiao D, Wu K . Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer. Front Immunol. 2022; 13:827921. PMC: 8977417. DOI: 10.3389/fimmu.2022.827921. View

4.
Xie S, Tao D, Fu Y, Xu B, Tang Y, Steinaa L . Rapid Visual CRISPR Assay: A Naked-Eye Colorimetric Detection Method for Nucleic Acids Based on CRISPR/Cas12a and a Convolutional Neural Network. ACS Synth Biol. 2021; 11(1):383-396. DOI: 10.1021/acssynbio.1c00474. View

5.
Huang M, Yang J, Wang T, Song J, Xia J, Wu L . Homogeneous, Low-volume, Efficient, and Sensitive Quantitation of Circulating Exosomal PD-L1 for Cancer Diagnosis and Immunotherapy Response Prediction. Angew Chem Int Ed Engl. 2020; 59(12):4800-4805. DOI: 10.1002/anie.201916039. View